Meilleure Health International Industry Group Limited (HKG:2327)
Hong Kong
· Delayed Price · Currency is HKD 0.290
+0.010 (3.57%)
Apr 29, 2026, 3:56 PM HKT
HKG:2327 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 36.52 | 50.68 | 129.3 | 119.89 | 253.03 | Upgrade
|
| Revenue Growth (YoY) | -27.94% | -60.81% | 7.85% | -52.62% | -4.57% | Upgrade
|
| Cost of Revenue | 13.89 | 22.73 | 52.09 | 53.14 | 152.1 | Upgrade
|
| Gross Profit | 22.63 | 27.95 | 77.21 | 66.76 | 100.93 | Upgrade
|
| Selling, General & Admin | 31.17 | 31.6 | 39.34 | 35.69 | 42.66 | Upgrade
|
| Operating Expenses | 32.34 | 31.8 | 41.83 | 35.93 | 43.58 | Upgrade
|
| Operating Income | -9.71 | -3.85 | 35.38 | 30.83 | 57.35 | Upgrade
|
| Interest Expense | -9.29 | -10.29 | -11.41 | -11.45 | -8.39 | Upgrade
|
| Interest & Investment Income | 29.3 | 22.5 | 19.87 | 27.21 | 13.54 | Upgrade
|
| Earnings From Equity Investments | -4.12 | -3.02 | -4.35 | -14.77 | -11.07 | Upgrade
|
| Currency Exchange Gain (Loss) | 8.38 | 4.01 | -0.24 | -5.57 | -9.94 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.46 | 12.41 | -11.3 | 4.63 | -2.92 | Upgrade
|
| EBT Excluding Unusual Items | 15.02 | 21.76 | 27.95 | 30.89 | 38.57 | Upgrade
|
| Impairment of Goodwill | - | -18.5 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -5.32 | 19.38 | 5.77 | -19.24 | 31.74 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.27 | 0.06 | 0.48 | 0 | - | Upgrade
|
| Asset Writedown | 21.73 | 23.81 | 18.54 | 13.58 | 15.18 | Upgrade
|
| Other Unusual Items | -1.17 | -1.1 | 0.24 | 0.15 | 0.21 | Upgrade
|
| Pretax Income | 30.54 | 45.4 | 52.98 | 25.39 | 85.7 | Upgrade
|
| Income Tax Expense | -7.46 | 13.36 | 14.49 | 7.61 | 25.25 | Upgrade
|
| Earnings From Continuing Operations | 38 | 32.05 | 38.49 | 17.78 | 60.46 | Upgrade
|
| Minority Interest in Earnings | -0.02 | 0.44 | 2.34 | 0.04 | -0.13 | Upgrade
|
| Net Income | 37.98 | 32.48 | 40.83 | 17.82 | 60.32 | Upgrade
|
| Net Income to Common | 37.98 | 32.48 | 40.83 | 17.82 | 60.32 | Upgrade
|
| Net Income Growth | 16.94% | -20.45% | 129.10% | -70.46% | -27.70% | Upgrade
|
| Shares Outstanding (Basic) | 4,064 | 4,093 | 4,093 | 4,109 | 4,257 | Upgrade
|
| Shares Outstanding (Diluted) | 4,064 | 4,093 | 4,093 | 4,110 | 4,266 | Upgrade
|
| Shares Change (YoY) | -0.70% | -0.02% | -0.41% | -3.66% | -0.13% | Upgrade
|
| EPS (Basic) | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | Upgrade
|
| EPS Growth | 17.72% | -20.79% | 132.01% | -69.51% | -27.69% | Upgrade
|
| Free Cash Flow | -50.02 | 185.86 | -137.32 | 42.14 | -89.75 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | 0.04 | -0.03 | 0.01 | -0.02 | Upgrade
|
| Dividend Per Share | 0.005 | 0.004 | 0.004 | 0.016 | - | Upgrade
|
| Dividend Growth | 37.50% | - | -75.00% | - | - | Upgrade
|
| Gross Margin | 61.97% | 55.15% | 59.71% | 55.68% | 39.89% | Upgrade
|
| Operating Margin | -26.59% | -7.61% | 27.36% | 25.71% | 22.66% | Upgrade
|
| Profit Margin | 104.01% | 64.09% | 31.58% | 14.87% | 23.84% | Upgrade
|
| Free Cash Flow Margin | -136.97% | 366.77% | -106.20% | 35.15% | -35.47% | Upgrade
|
| EBITDA | -8.97 | -2.67 | 36.93 | 32.26 | 58.39 | Upgrade
|
| EBITDA Margin | -24.57% | -5.26% | 28.56% | 26.91% | 23.08% | Upgrade
|
| D&A For EBITDA | 0.74 | 1.19 | 1.55 | 1.43 | 1.04 | Upgrade
|
| EBIT | -9.71 | -3.85 | 35.38 | 30.83 | 57.35 | Upgrade
|
| EBIT Margin | -26.59% | -7.61% | 27.36% | 25.71% | 22.66% | Upgrade
|
| Effective Tax Rate | - | 29.42% | 27.35% | 29.96% | 29.46% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.